Safety and Efficacy of Exemestane Plus Dasatinib Versus Placebo for Advanced ER+ Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Exemestane + Dasatinib|DRUG: Exemestane + Placebo
Sponsor: Bristol-Myers Squibb